Encompass Compliance

Encompass Compliance FCF Conversion

The FCF Conversion Rate (FCF/EBITDA) of Encompass Compliance (ENCC) as of Nov 3, 2026 is -0.53 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was -0.81 % — a change of -34.86% (higher).

FCF Conversion

-0.53 %

YoY

-34.86%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of Encompass Compliance is 2019 -0.53 % . FCF Conversion Rate (FCF/EBITDA) of Encompass Compliance was 2018 -0.81 % . It decreases by -34.86% higher compared to the previous year.

The Encompass Compliance FCF Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Conversion
Date
FCF Conversion
Jan 1, 2015
0.46 USD
Jan 1, 2016
-20.80 USD
Jan 1, 2017
-0.81 USD
Jan 1, 2019
-0.53 USD
The Encompass Compliance FCF Conversion history
YEARFCF ConversionYoY
-0.53 %-34.86%
-0.81 %-96.11%
-20.80 %-4,605.41%
0.46 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Encompass Compliance Stock analysis

What does Encompass Compliance do? Encompass Compliance Corp provides workplace drug and alcohol testing compliance services through an annual subscription model. The company's offerings include the Drug Testing Compliance Matrix, statutes, regulations, and court decisions to help employers maintain compliance. It focuses on Medical Marijuana, Opiates, Synthetics, and other drugs and alcohol usage, delivering solutions like Risk Shield for creating core policies and real-time monitoring for testing orders. Customers are employers seeking to manage workplace drug and alcohol testing regulations. The firm offers training modules, consulting services, and Claims defense to support implementation and policy management. Its resource center provides up-to-date policies and guidance on evolving legal impacts. Encompass Compliance Corp's annual subscription service updates employers on regulatory changes, ensuring ongoing compliance with workplace testing laws. Risk Shield is a key product that allows employers to build core drug and alcohol policies while accounting for all applicable regulations. The company's services target organizations needing to navigate complex drug testing laws, particularly in sectors where Medical Marijuana, Opiates, and Synthetics are relevant. Training tools and real-time monitoring features enhance the value proposition for employers managing workplace safety. Encompass Compliance is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Encompass Compliance stock

FCF Conversion Rate (FCF/EBITDA) of Encompass Compliance is -0.53 % in 2019.

FCF Conversion Rate (FCF/EBITDA) of Encompass Compliance changed from -0.81 % to -0.53 %, representing a -34.86% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) Encompass Compliance since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s Encompass Compliance with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Encompass Compliance

All Key Metrics — Encompass Compliance